Announcement PDF For more information, please join ABx Group’s interactive Investor Hub ABx Group Limited Suite 2, Level 11, 385 Bourke St, Melbourne VIC 3000, Australia ABN 14 139 494 885 |P: +61 3 9692 7222 | F: +61 2 9956 7355 $4.1M Secured to Advance Rare Earths and ALCORE Engage with this announcement on our interactive Investor Hub Binding commitments received for the full Placement amount of $2.1 million Eligible shareholders offered the opportunity to participate in a fully underwritten Share Purchase Plan to raise $2.0 million ABx strategic partner Good Importing International has committed to invest $1.0 million in the Placement, with the balance supported by other existing and new investors ABx Group Limited (ASX: ABX) (ABx or the Company) is undertaking a capital raising of approximately $4.1 million through a placement to professional and sophisticated investors and a share purchase plan for eligible shareholders. ABx strategic partner Good Importing International (GII) has committed to invest $1.0 million in the placement. Board and management have made binding commitments of $100,000 to support the placement, subject to shareholder approval, and intend to commit an additional $60,000 to the share purchase plan. The capital raising will support the advancement of the Company's Deep Leads rare earths project in Tasmania and the construction and commissioning of the ALCORE pilot plant, together with working capital and offer-related costs. CAPITAL RAISING The Company is undertaking a capital raising to raise approximately $4.1 million, comprising: • a Placement to raise approximately $2.1 million (Placement); and • a fully underwritten Share Purchase Plan to raise $2.0 million (SPP), (together, the Capital Raising). PLACEMENT The Placement will result in the issuance of approximately 67.7 million new fully paid ordinary shares (Placement Shares) at an issue price of $0.031 (3.1 cents) per share with approximately 33.8 million attaching options, exercisable at $0.046 (4.6 cents) expiring 3 years from the date of issue, on the basis of one (1) option for every two (2) new shares subscribed for and issued (Placement Options). The issue price of $0.031 represents an 18% discount to the 15-day VWAP of $0.0378. ASX Announcement 17 September 2026 ASX: ABX ASX announcement 17 September 2026 page 2 All Placement Shares will be issued under the Company’s ASX L.R. 7.1 and 7.1A placement capacity, with the exception of $100,000 of Board Placement Shares which will be issued subject to shareholder approval, and be issued as follows: • 27,024,335 Placement Shares under the Company’s existing Placement Capacity under ASX Listing Rule 7.1; • 37,491,794 Placement Shares under the Company’s existing Placement Capacity under ASX Listing Rule 7.1A; and • 3,225,806 Placement Shares to a Director subject to shareholder approval. All attaching options and lead manager options to be issued under the Placement, and new fully paid ordinary shares and free attaching options issued under the SPP, will be subject to shareholder approval at an Extraordinary General Meeting to be held on or about Thursday, 29 October 2026. Alpine Capital Pty Ltd acted as lead manager (Lead Manager) to the Placement. The Lead Manager will receive a 3.0% management fee on all funds, 3.0% selling fee on the gross proceeds raised under the Placement (excluding funds raised under the Chair’s List), and approximately 13.5 million Lead Manager Options on the same terms as the Placement Options. FULLY UNDERWRITTEN SHARE PURCHASE PLAN In addition to the Placement, the Company will offer eligible shareholders with a registered address in Australia or New Zealand the opportunity to participate in a fully underwritten Share Purchase Plan, under which $2.0 million is to be raised through the issue of new fully paid ordinary shares (SPP Shares) at the lower of the Placement price or 95% of the VWAP of Shares traded on ASX over the five (5) Trading Days up to and including the Closing Date (rounded down to the nearest $0.001). Participants will also receive one (1) free attaching new option (SPP Options) for every two (2) SPP Shares subscribed for and issued, exercisable at $0.046 (4.6 cents) and expiring three years from the date of issue (together, the SPP Securities). Eligible shareholders will be entitled to apply for up to A$30,000 worth of SPP Shares, to raise $2.0 million before costs. Full details of the SPP, including any scale back of applications in the event of oversubscriptions, will be contained in the SPP Prospectus which is expected to be despatched on or around Monday, 28 September 2026. The SPP Securities will be subject to shareholder approval as they do not meet the requirements under ASX Listing Rule 7.2 exception 5. Alpine Capital Pty Ltd (Underwriter) has agreed to fully underwrite the $2.0 million SPP. The Underwriter will receive a 3% management fee and a 3% selling fee on the underwritten amount, and will receive two (2) options for each one (1) share underwritten, on the same terms as the Company’s already quoted ABXO options. ASX announcement 17 September 2026 page 3 SHAREHOLDER APPROVALS As indicated above, the Company intends to convene an Extraordinary General Meeting (EGM) to seek shareholder approvals required in connection with the Capital Raising, including all options associated with the Capital Raising. INDICATIVE TIMETABLE The intended timetable for the Placement and SPP is as follows: Event Details Date (and time if relevant) SPP Record Date The date and time that eligibility to participate in the SPP was determined. 7:00pm (AEST) Wednesday, 16 September 2026 Announcement – Placement & SPP The announcement of Placement Securities and SPP Options and lodgement of Appendix 3B with ASX. Thursday, 17 September 2026 SPP Prospectus dispatched & Offer Open Lodge Prospectus with ASIC and ASX. Send Prospectus and Application Form to Shareholders (other than Excluded Shareholders). Announce that Prospectus has been sent to Shareholders and SPP has opened. Lodge Appendix 3B with ASX for quotation of the SPP Shares and Underwriter Options. Monday, 28 September 2026 EGM Notice of Meeting dispatched Lodgement of the Notice of EGM with the ASX and despatch to shareholders. Monday, 28 September 2026 Closing Date SPP offer closes. Applications must be received by 5:00pm (AEST). Friday, 23 October 2026 Shortfall Notice Deadline Date Notification of any shortfall under the SPP and underwriting arrangements. Monday, 26 October 2026 Shortfall Settlement Date Settlement of any SPP shortfall securities. Thursday, 29 October 2026 Hold EGM Shareholder meeting to approve Placement Options, SPP Securities, Underwriter Options and related resolutions. Thursday, 29 October 2026 SPP Results announcement Issue date of SPP Shares and lodgement of Appendix 2A with ASX applying for quotation of the SPP Shares following EGM approval. Before 12:00pm (AEDT) Friday, 30 October 2026 Commencement of trading SPP Shares SPP Securities commence trading on the ASX (subject to ASX Listing Rules). Monday, 2 November 2026 *The above timetable is indicative only and subject to change. Subject to the ASX Listing Rules and Corporations Act and other applicable laws, the Company reserves the right to vary these dates, without notice. Any extension of the SPP will have a consequential effect on the issue date of the new shares. ASX announcement 17 September 2026 page 4 Dr Mark Cooksey, Managing Director and CEO of ABx Group, commented: “This funding provides ABx with additional financial capacity to accelerate our key development priorities across rare earths and ALCORE. “We have important work programs underway across both businesses, from advancing Deep Leads and our rare earths commercialisation strategy to progressing ALCORE’s continuous pilot plant at Bell Bay. This funding puts us in a stronger position to maintain that momentum. “We are particularly pleased to have the continued support of GII through its $1 million investment in the placement. GII is already an important strategic partner to ABx through our bauxite assets, and its participation further strengthens that relationship. “The placement is also supported by other existing and new investors, while the underwritten SPP provides our eligible existing shareholders with the opportunity to participate in the capital raising.” This announcement is approved for release by the board of ABx Group Limited. Go to the ABx Investor Hub ask any questions of management. For further information please contact: Dr Mark Cooksey MD & CEO ABx Group +61 447 201 536 mcooksey@abxgroup.com.au www.abxgroup.com.au Media Chapter One Advisors David Tasker / Alex Baker +61 433 112 936 / +61 432 801 745 dtasker@chapteroneadvisors.com.au / abaker@chapteroneadvisors.com.au About ABx Group Limited ABx Group is developing heavy rare earths, hydrogen fluoride and bauxite projects in Australia. ABx is a uniquely positioned Australian company delivering materials for a safer, cleaner future. The three priority projects are: • Heavy rare earths: Supplying light and heavy rare earths from Tasmania into Western supply chains o Maiden mixed rare earth carbonate produced and positive feedback received from multiple customers o Processing Options Analysis conducted in partnership with external experts • Clean fluorine chemical production: Producing hydrogen fluoride from aluminium smelter by-product (ALCORE) o Continuous pilot plant under construction in Bell Bay, Tasmania ASX announcement 17 September 2026 page 5 • Near-term bauxite production: Mining bauxite for the aluminium, cement and fertiliser industries o Agreements executed with Good Importing International for bauxite projects in Queensland, and $2.7 million initial payment has been received o Approvals well advanced for DL130 bauxite project in northern Tasmania ABx endorses best practices on agricultural land and strives to leave land and environment better than we find it. We only operate where welcomed. Disclaimer Regarding Forward Looking Statements This ASX announcement (Announcement) contains various forward-looking statements. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are inherently subject to uncertainties in that they may be affected by a variety of known and unknown risks, variables and factors which could cause actual values or results, performance, or achievements to differ materially from the expectations described in such forward-looking statements. ABx does not give any assurance that the anticipated results, performance, or achievements expressed or implied in those forward-looking statements will be achieved.